Fluzone Hd Tiv Sh 2026 Injection, Suspension
Product Images NDC 49281-016

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Fluzone Hd Tiv Sh 2026 (NDC 49281-016). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sanofi Vaccines Us Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (0.5 mL Syringe Label)

Label of Fluzone High-Dose 2025 Influenza Vaccine for the Southern Hemisphere, injection suspension in a 0.5 mL single-dose vial. It indicates no preservative and is for intramuscular use in individuals 65 years and older. The label includes lot and expiration placeholders, barcode, and manufacturer Sanofi Pasteur Inc.*

FDA Label Image

Principal Display Panel (0.5 mL 10 Syringe Carton)

Carton packaging for Fluzone High-Dose Southern Hemisphere Influenza Vaccine 2025 Formula. The product is an intramuscular injection suspension, packaged as 10 single-dose prefilled syringes of 0.5 mL each. It is labeled for adults 65 years and older and manufactured by Sanofi. The label includes storage instructions, vaccine strain information, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.